金
01548
金斯瑞生物科技
13.680
-0.280-2.01%Closed16:08 05/29 HKT
OPEN/PREV CLOSE13.960/12.140
TODAY RANGE13.960-15.600
VOL39.11M
MARKET CAP31.42B
52 WEEK RANGE10.360-19.400
AVG VOL (3M)11.11M
% TURNOVER1.79%
TURNOVER569.78M
P/E (TTM)-7.578
% RANGE13.51%
EPS(TTM)-1.895
P/E(FORWARD)53.107
P/B1.020
BVPS14.081
DIVIDEND--
P/S4.208
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP31.42B
SHARES OUTSTANDING2.19B
NEXT EARNINGS08/14-08/18
FREE FLOAT2.19B
LOT SIZE2000
EX-DATE--
News
Press Releases
Financial Reports
Profile
The Wall Street Journal·5d ago
J&J Mastered Cancer Biotech Deals on the Cheap. Can it Stay on the Cutting Edge? -- Heard on the Street
Simply Wall St·05/09 03:52
A Look At Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Momentum
Simply Wall St·04/24 18:11
Is It Time To Reassess Genscript Biotech (SEHK:1548) After Its Recent Share Price Recovery?
Simply Wall St·04/23 03:12
Genscript Biotech Governance Reset Puts Shareholder Rights Under Fresh Focus
PUBT·04/14 12:04
GenScript announces availability of 2025 ESG report
Simply Wall St·04/13 15:19
A Look At GenScript Biotech (SEHK:1548) Valuation After New DNA Data Storage Collaboration With Mimulus
PUBT·04/13 10:07
GenScript Biotech announces annual general meeting notice
PUBT·04/13 09:08
GenScript Biotech publishes 2025 annual report
Reuters·04/09 12:06
GenScript partners with Mimulus to scale DNA-based data storage by 2030
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.